Haven't had much time lately? Here's what you may have missed in the last few months
25 Nov 2016
A large patient cohort study suggests that use of androgen deprivation therapy does not increase the likelihood of developing dementia
25 Nov 2016
Did you know? How medwireNews Writes our Articles
24 Nov 2016
Secondary endpoint findings for the Persephone trial show less cardiotoxicity in early-stage HER2-positive breast cancer patients given 6 months of...
23 Nov 2016
Overall survival in advanced epithelial ovarian cancer patients aged less than 70 years without comorbidity is higher with primary cytoreductive surgery...
22 Nov 2016
Analysis of data from four clinical trials shows that the side effects of nivolumab monotherapy are generally low grade and resolvable
C. Cremolini digs into how tumour side impact on efficacy of molecular targeted therapy in colon cancer and markers of EGFR resistance in right side tumours. She underlines a need for more intensified first-line treatment in RAS and BRAF wt right side colon cancer (triple chemo and Antiangiogenic Antibody). More research is needed to understand why some patients with right side, RAS and BRAF wt colon cancer may derive benefit from anti-EGFR mAb, while some patients with left side Ras and BRAF wt tumours do not respond.